Skip to main content
SpringerLink
Log in

Cisapride marketing to end due to heart arrhythmia risks

  • Abstract
  • Published:
The Indian Journal of Pediatrics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cisapride marketing to end due to heart arrhythmia risks. Indian J Pediatr 67, 687 (2000). https://doi.org/10.1007/BF02762186

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02762186

Keywords

Search

Navigation